de Almeida, B.C.; dos Anjos, L.G.; Kagohara, L.T.; Al-Hendy, A.; Yang, Q.; Baracat, E.C.; Coutinho-Camillo, C.M.; Carvalho, K.C.
Could let-7f, miR-10b, miR-34a, miR-181b, and miR-181d Be Useful Tools as a Target Therapy for Uterine Leiomyosarcoma? Biomedicines 2025, 13, 560.
https://doi.org/10.3390/biomedicines13030560
AMA Style
de Almeida BC, dos Anjos LG, Kagohara LT, Al-Hendy A, Yang Q, Baracat EC, Coutinho-Camillo CM, Carvalho KC.
Could let-7f, miR-10b, miR-34a, miR-181b, and miR-181d Be Useful Tools as a Target Therapy for Uterine Leiomyosarcoma? Biomedicines. 2025; 13(3):560.
https://doi.org/10.3390/biomedicines13030560
Chicago/Turabian Style
de Almeida, Bruna Cristine, Laura Gonzalez dos Anjos, Luciane Tsukamoto Kagohara, Ayman Al-Hendy, Qiwei Yang, Edmund Chada Baracat, Cláudia Malheiros Coutinho-Camillo, and Katia Candido Carvalho.
2025. "Could let-7f, miR-10b, miR-34a, miR-181b, and miR-181d Be Useful Tools as a Target Therapy for Uterine Leiomyosarcoma?" Biomedicines 13, no. 3: 560.
https://doi.org/10.3390/biomedicines13030560
APA Style
de Almeida, B. C., dos Anjos, L. G., Kagohara, L. T., Al-Hendy, A., Yang, Q., Baracat, E. C., Coutinho-Camillo, C. M., & Carvalho, K. C.
(2025). Could let-7f, miR-10b, miR-34a, miR-181b, and miR-181d Be Useful Tools as a Target Therapy for Uterine Leiomyosarcoma? Biomedicines, 13(3), 560.
https://doi.org/10.3390/biomedicines13030560
